<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04761328</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY19110214</org_study_id>
    <nct_id>NCT04761328</nct_id>
  </id_info>
  <brief_title>Distress and Immunotherapy</brief_title>
  <official_title>Distress Associated With Stopping Immunotherapy of Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study includes participants experiencing distress with regard to stopping immunotherapy&#xD;
      and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and&#xD;
      anxiety and improve quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intervention will be delivered through telemedicine to reduce the patient-related&#xD;
      barriers to treatment including cost, transportation, and being able to maintain appointments&#xD;
      while managing the side effects of treatment. The intervention will provide the patient with&#xD;
      skills to reduce distress associated with ceasing treatment of a checkpoint inhibitor through&#xD;
      the development evidence-based psychological and behavioral strategies that are tailored to&#xD;
      the patients' preferences.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All patients will receive treatment and be evaluated pre- and post-treatment</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduce fear of recurrence</measure>
    <time_frame>3 months</time_frame>
    <description>Change by 50%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improve quality of life</measure>
    <time_frame>3 months</time_frame>
    <description>Change of quality of life by 5 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of anxiety</measure>
    <time_frame>3 months</time_frame>
    <description>Change of anxiety by 2 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms</measure>
    <time_frame>3 months</time_frame>
    <description>Change by 25%</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cognitive Behavioral Therapy</condition>
  <arm_group>
    <arm_group_label>Cessation of treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cognitive behavioral therapy</intervention_name>
    <description>Cognitive-behavioral therapy involves changing these erroneous cognitions and beliefs through cognitive restructuring, modification of behavior, and development of alternative coping skills.</description>
    <arm_group_label>Cessation of treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 21 years and older&#xD;
&#xD;
          -  Fluent in English&#xD;
&#xD;
          -  Diagnosis of cancer and history of treatment with immunotherapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active suicidal ideation, delusions or hallucinations&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jennifer L Steel, Ph.D.</last_name>
    <phone>412-692-2041</phone>
    <email>steejl@upmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UPMC Hillman Cancer Centers</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer L Steel, Ph.D.</last_name>
      <phone>412-692-2041</phone>
      <email>steejl@upmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 16, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Jennifer Steel</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Fear of recurrence</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Depression</keyword>
  <keyword>Anxiety</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

